Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Low-dose amisulpride and elevation in serum prolactin.

Andrade C.

J Clin Psychiatry. 2013 Jun;74(6):e558-60. doi: 10.4088/JCP.13f08510. No abstract available.

PMID:
23842026
2.

Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients.

Lee BH, Kang SG, Kim TW, Lee HJ, Yoon HK, Park YM.

Psychiatry Clin Neurosci. 2012 Feb;66(1):69-73. doi: 10.1111/j.1440-1819.2011.02296.x.

3.

Amisulpride-induced hyperprolactinemia is reversible following discontinuation.

Paparrigopoulos T, Liappas J, Tzavellas E, Mourikis I, Soldatos C.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):92-6. Epub 2006 Aug 28.

PMID:
16938372
4.

Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.

Paulzen M, Gründer G.

Int J Neuropsychopharmacol. 2007 Feb;10(1):149-51. Epub 2006 Aug 31. No abstract available.

PMID:
16942633
5.

Hyperprolactinemia after low dose of amisulpride.

Kopecek M, Bares M, Svarc J, Dockery C, Horácek J.

Neuro Endocrinol Lett. 2004 Dec;25(6):419-22.

PMID:
15665803
6.

New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.

Moro M, Inada Y, Kojima M, Miyata H, Komatsu H, Torii R.

Eur J Pharmacol. 1999 Feb 26;368(1):57-66.

PMID:
10096770
7.

Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.

Bliesener N, Yokusoglu H, Quednow BB, Klingmüller D, Kühn KU.

Pharmacopsychiatry. 2004 Jul;37(4):189-91. No abstract available.

PMID:
15467977
8.

Effect of the amisulpride isomers on rat prolactinemia.

Marchese G, Ruiu S, Casti P, Saba P, Gessa GL, Pani L.

Eur J Pharmacol. 2002 Jul 19;448(2-3):263-6.

PMID:
12144950
9.

Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect.

Marchese G, Ruiu S, Casti P, Bartholini F, Saba P, Gessa GL, Pani L.

Eur J Pharmacol. 2002 Jun 28;447(1):109-14.

PMID:
12106810
10.

Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.

Kopecek M, Bares M, Horácek J.

Neuro Endocrinol Lett. 2005 Aug;26(4):320. No abstract available.

PMID:
16136015
11.

Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.

Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS.

J Clin Psychopharmacol. 2008 Jun;28(3):349-52. doi: 10.1097/JCP.0b013e318172755a. No abstract available.

PMID:
18480697
12.

Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.

Kim EY, Kim SH, Lee NY, Jung DC, Kim YS, Ahn YM.

Pharmacopsychiatry. 2012 Mar;45(2):57-63. doi: 10.1055/s-0031-1291175. Epub 2012 Mar 12.

PMID:
22411694
13.

[The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

Müller-Vahl KR.

Nervenarzt. 2007 Mar;78(3):264, 266-8, 270-1. Review. German.

PMID:
16924461
14.

Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.

Arakawa R, Okumura M, Ito H, Takano A, Takahashi H, Takano H, Maeda J, Okubo Y, Suhara T.

J Clin Psychiatry. 2010 Sep;71(9):1131-7. doi: 10.4088/JCP.08m04307yel. Epub 2010 Feb 23.

PMID:
20361897
15.

Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.

Bressan RA, Erlandsson K, Spencer EP, Ell PJ, Pilowsky LS.

Psychopharmacology (Berl). 2004 Sep;175(3):367-73.

PMID:
14997280
16.

Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.

Akkaya C, Kaya B, Kotan Z, Sarandol A, Ersoy C, Kirli S.

J Psychopharmacol. 2009 Aug;23(6):723-6. doi: 10.1177/0269881108091252. Epub 2008 Jun 18.

PMID:
18562408
17.

[Changes in the endocrine system in the course of sulpiride therapy].

Roś LT.

Pol Merkur Lekarski. 2001 Dec;11(66):532-4. Review. Polish.

PMID:
11899856
18.

Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.

Svestka J, Synek O, Tomanová J, Rodáková I, Cejpková A.

Neuro Endocrinol Lett. 2007 Dec;28(6):881-8.

PMID:
18063941
19.

Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.

Saitis M, Papazisis G, Katsigiannopoulos K, Kouvelas D.

Psychiatry Clin Neurosci. 2008 Oct;62(5):624. doi: 10.1111/j.1440-1819.2008.01859.x. No abstract available.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk